Clinical trials
Color Vision Defects trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2022 | 1 |
| 2023 | 4 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 4 |
| Suspended | 3 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beacon Therapeutics | 3 |
| MeiraGTx UK II Ltd | 3 |
| University of California, San Francisco | 3 |
| University of Colorado, Denver | 2 |
| University of Oklahoma | 2 |
| Alaska Blind Child Discovery | 1 |
| Columbia University | 1 |
| Emory University | 1 |
| Foundation Fighting Blindness | 1 |
| GIE Medical | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Color Vision Defects | 27 |
| Corticobasal Degeneration | 3 |
| Eye Diseases | 2 |
| Primary Progressive Nonfluent Aphasia | 2 |
| Retinitis Pigmentosa | 2 |
| Supranuclear Palsy, Progressive | 2 |
| Abetalipoproteinemia | 1 |
| Alcoholism | 1 |
| Amblyopia | 1 |
| Amyotrophic Lateral Sclerosis | 1 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.